Studies have shown that the PTEN inhibitor bisperoxovanadium can restore the cardioprotective effect of RIC in hyperlipidemia rats, which may be related to promoting downstream Akt/GSK-3β phosphorylation (134). Here, GSK3B is linked to hyperlipidemia.